Latest News for: cld

Edit

Caldera Therapeutics Launches with $112.5 Million and Announces First Subjects Dosed in Phase 1 Trial of First-In-Class Bispecific Antibody CLD-423 for Inflammatory Bowel Disease

Pharmiweb 14 Jan 2026
Proceeds will fund ongoing clinical development of CLD-423, a bispecific antibody targeting the clinically validated IL-23p19 and TL1A pathways ... CLD-423 is advancing through Phase 1 with the goal of enabling clinical evaluation in patients with IBD.”.
Edit

Space CEO explains why he believes private space stations are a viable business

Ars Technica 01 Dec 2025
It’s a critical time for companies competing to develop a commercial successor to the International Space Station ... Read full article. Comments .
  • 1

Article Search

tools
×
×
×
×